Boston Scientific Corporation (BSX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Boston Scientific Corporation  (NYSE: BSX)


Boston Scientific's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Boston Scientific's ROI in the second quarter of 2026?
Boston Scientific Corporation achieved a return on average invested assets (ROI) of 9.97 % in its second quarter of 2026, this is above BSX's average return on investment of 0.47%.
Boston Scientific Corporations investments during the 12 months ending in the second quarter of 2026 are valued at $36 billion

ROI decreased relative to the period ending Mar 31 2026, due to the decline in net income.

Within the Healthcare sector 90 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 820 to 833.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 14.24 % 14.01 % 13.68 % 12.5 % 11.18 %
Y / Y Net Income Change TTM 46.88 % 75.75 % 113.75 % 252.53 % 675.78 %
Investment (TTM) in Millions 39,030 37,332 35,848 34,983 33,995
Return On Investment (TTM) 9.97 % 10.01 % 8.38 % 8.35 % 7.75 %
BSX's Overall Ranking # 833 # 820 # 814 # 880 # 356
Seq. Investment Change TTM 3.54 % 2.99 % 3.48 % 3.53 % 3.33 %
Seq. Net Income Change TTM 3.09 % 23.06 % 3.84 % 11.49 % 23.36 %
Net Income (TTM) in Millions 3,669 3,559 2,892 2,785 2,498

BSX Company Profile >> Back to BSX Roi Comparisons >> See Annual BSX Return On Investment



Return On Investment BSX's Ranking
Within: No.
Industry # 30
Sector # 91
Overall # 833

Return On Investment Statistics
High Average Low
22.36 %
0.47 %
-31.45 %
(Dec 31 2019)   (June 30, 2006)







Financial Statements
Boston Scientific's II. Quarter Investments $ 39,030 Millions BSX's Balance sheet
Boston Scientific's II. Quarter Income $ 905 Millions Quarterly BSX's Income Statement
BSX's Income by Division See BSX's Income by Division


BSX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 35,848 31,204 28,349 26,488 27,955
Y / Y Investment Growth 14.88 % 10.07 % 7.03 % -5.25 % 3.17 %
Net Income in Millions 2,892 1,846 1,592 698 1,041
Y / Y Net Income Growth 56.66 % 15.95 % 128.08 % -32.95 % -
Annual Return On Investment 8.07 % 5.92 % 5.62 % 2.64 % 3.72 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 8.07 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BSX's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BSX's Competitors
Subscribers only: Roi for Boston Scientific's Suppliers
Subscribers only: Return On Investment for BSX's Customers

Other Ratios
BSX's Roa BSX's Inventory Turnover Ratio BSX's Growth Rates BSX's Dividend Statistics
BSX's Profitability Ratios BSX's Asset Turnover Ratio BSX's Dividend Growth
BSX's Roe BSX's Valuation Ratios BSX's Financial Strength Ratios BSX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %

Date modified: 2026-09-12T18:17:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.